Highlights
- •The real disease burden of Chronic hepatitis C (CHC) infection is underestimated.
- •Epidemiological trends of CHC infection and its clinical stages.
- •Provides a framework to evaluate future healthcare policies.
Abstract
Objective
Methods
Results
Conclusion
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineReferences
World Health Organization. WHO fact sheets Hepatitis C.Available: https://wwwwhoint/en/news-room/fact-sheets/detail/hepatitis-c [Accessed: 08-Jul-2019]. 2019.
- Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.Lancet Gastroenterol Hepatol. 2017; 2: 161-176
European Centre for Disease Prevention and Control. Hepatitis C. Annual epidemiological report for2017. Stockholm2019.
- Resultados del 2° estudio de seroprevalencia en España (2017-2018) Madrid: ministerio de Sanidad.Consumo Bienestar Social. 2019;
- Natural history of hepatitis C.Gastroenterol Clin North Am. 2015; 44: 717-734
- Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C.J Hepatol. 2001; 34: 730-739
- Natural history of hepatitis C.J Hepatol. 2014; 61: S58-S68
- Natural history and management of hepatitis C: does sex play a role?.J Infect Dis. 2014; 3 (209 Supp): S81-S85
- Triple therapy with boceprevir or telaprevir for treatment naive HCV patients.Best Pract Res Clin Gastroenterol. 2012; 26: 445-453
- EASL clinical practice guidelines: management of hepatitis C virus infection.J Hepatol. 2014; 60: 392-420
- Electronic address eee. EASL recommendations on treatment of Hepatitis C 2016.J Hepatol. 2017; 66: 153-194
- Management of acute HCV infection in the era of direct-acting antiviral therapy.Nat Rev Gastroenterol Hepatol. 2018; 15: 412-424
- Comorbidity, concomitant medication, use of resources and healthcare costs associated with chronic hepatitis C virus carriers in Spain.Gastroenterol Hepatol. 2018; 41: 234-244
- Direct medical costs associated with the extrahepatic manifestations of hepatitis c infection in Europe.J Viral Hepat. 2018; 25: 811-817
- Economic burden of cirrhosis in Catalonia: a population-based analysis.BMJ Open. 2018; 8e018012
- Progress in the elimination of hepatitis C virus infection: a population-based cohort study in Spain.PLoS ONE. 2018; 13e0208554
- Incidence of hepatocellular carcinoma in patients with HCV-Associated cirrhosis treated with direct-acting antiviral agents.Gastroenterology. 2018; 155 (e414): 411-421
- Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.Lancet. 2019; 393: 1453-1464
- Budgetary impact analysis of a primary care-based hepatitis C treatment program: effects of 340B drug pricing program.PLoS ONE. 2019; 14e0213745
- Streamlining the screening cascade for active Hepatitis C in Russia: a cost-effectiveness analysis.PLoS ONE. 2019; 14e0219687
Subdirección General de Información Sanitaria e Innovación. Registro de Actividad de Atención Especializada. RAE-CMBD [https://www.msssi.gob.es/estadEstudios/estadisticas/cmbdhome.htm] In:2016.
- Hepatitis C hospitalizations in Spain, 2004-2013: a retrospective epidemiological study.BMC Health Serv Res. 2017; 17: 461
- The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.J Viral Hepat. 2014; 21 (Suppl 1): 34-59
- Hospitalizations and costs associated with hepatitis C and advanced liver disease continue to increase.Health Aff (Millwood). 2014; 33: 1728-1735
- Ten years of hospital admissions for liver cirrhosis in Portugal.Eur J Gastroenterol Hepatol. 2015; 27: 1320-1326
- Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.Gastroenterology. 2015; 149 (e1475; quiz e1417-1478): 1471-1482
- Increasing hospitalization rates for cirrhosis: overrepresentation of disadvantaged Australians.E Clin Med. 2019; 11: 44-53
- Nationwide increase in hospitalizations and hepatitis C among inpatients with cirrhosis and sequelae of portal hypertension.Clin Gastroenterol Hepatol. 2007; 5: 1092-1099
- Trends in hospitalizations for chronic liver disease-related liver failure in the United States.Liver Int. 2019; : 2005-2014
- Disease burden of hepatitis C in the Austrian state of tyrol – Epidemiological data and model analysis to achieve elimination by 2030.PLoS ONE. 2018; 13e0200750
- The present and future disease burden of hepatitis C virus infections with today's treatment paradigm.J Viral Hepat. 2015; 3 (22 Suppl 4): 21-41
- Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.J Hepatol. 2019; 71: 281-288
- Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study.BMJ Open. 2019; 9e026726
- Future complications of chronic hepatitis C in a low-risk area: projections from the hepatitis c study in Northern Norway.BMC Infect Dis. 2017; 17: 624
- The burden of liver disease in Europe: a review of available epidemiological data.J Hepatol. 2013; 58: 593-608
- Changing trends in etiology-based annual mortality from chronic liver disease, from 2007 through 2016.Gastroenterology. 2018; 155 (e1153): 1154-1163
- The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.Ann Intern Med. 2012; 156: 271-278
- Inpatient resource utilization, disease severity, mortality and insurance coverage for patients hospitalized for hepatitis C virus in the United States.J Viral Hepat. 2015; 22: 137-145
- The burden of hepatitis C virus infection is growing: a Canadian population-based study of hospitalizations from 1994 to 2004.Can J Gastroenterol. 2008; 22: 381-387
- Increasing volume but decreasing mortality of hospitalized hepatitis C patients in the United States, 2005 to 2011.J Clin Gastroenterol. 2015; 49: 620-627
Ministerio de Sanidad Servicios Sociales e Igualdad. Plan estratégico para el abordaje de la hepatitis c en el sistema nacional de salud; Available: https://www.mscbs.gob.es/ciudadanos/enfLesiones/enfTransmisibles/hepatitisC/PlanEstrategicoHEPATITISC/home.htm. [Accessed: 29-Jul-2019]. 2015.
- Natural history of liver-related disease in patients with chronic hepatitis C virus infection: an analysis using a Markov chain model.J Med Virol. 2019;
- Hospitalizations due to hepatitis C in Los Angeles County, 2007-2009: case characteristics and factors associated with mortality.J Viral Hepat. 2013; 20: 628-637
- Prognosis of 1169 hepatitis C chronically infected patients with decompensated cirrhosis in the predirect-acting antiviral era.J Viral Hepat. 2017; 24: 295-303
- Effects of the financial crisis and Troika austerity measures on health and health care access in Portugal.Health Policy (New York). 2016; 120: 833-839
- The impact of the financial crisis on human resources for health policies in three southern-Europe countries.Health Policy (New York). 2015; 119: 1600-1605
- A “Before and after” in the use of emergency services in Spain? The impact of the economic crisis.Int J Health Serv. 2016; 46: 430-447
- Value of treating all stages of chronic hepatitis C: a comprehensive review of clinical and economic evidence.Infect Dis Ther. 2016; 5: 491-508
- The validity of viral hepatitis and chronic liver disease diagnoses in veterans affairs administrative databases.Aliment Pharmacol Ther. 2008; 27: 274-282
- National estimates of healthcare utilization by individuals with hepatitis C virus infection in the United States.Clin Infect Dis. 2014; 59: 755-764